|
WO2021042066A1
|
|
Kmt2a-maml2 fusion molecules and uses thereof
|
|
WO2020243021A2
|
|
Ntrk fusion molecules and uses thereof
|
|
WO2020236941A1
|
|
Systems and methods for evaluating tumor fraction
|
|
BR112020024727A2
|
|
compositions and methods for evaluating genomic changes
|
|
MX2018010362A
|
|
Methods and systems for evaluating tumor mutational burden.
|
|
CN109476731A
|
|
The method for the treatment of cancer
|
|
CA2967447A1
|
|
Multigene analysis of tumor samples
|
|
EP3183678A1
|
|
System and method for managing genomic information
|
|
US2015023965A1
|
|
Methods of treating urothelial carcinoma
|
|
EP2994847A1
|
|
Analysis of genetic variants
|
|
KR20190100425A
|
|
Optimization of multigene analysis of tumor samples
|
